Claudin-3 expression increases the malignant potential of lung adenocarcinoma cells: role of epidermal growth factor receptor activation
Metrics: PDF 993 views | HTML 1319 views | ?
Lianmin Zhang1,*, Yuan Wang1,*, Bin Zhang1, Hua Zhang1, Meng Zhou1, Mei Wei1, Qiuping Dong1, Yue Xu1, Zhaosong Wang1, Liuwei Gao1, Yanjun Qu1, Bowen Shi1, Jinfang Zhu1, Yuesong Yin1, Yulong Chen1, Lu Sun1, Wei Zhang1, Shilei Xu1, Guoguang Ying1, Changli Wang1
1Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin, 300060, China
*These authors have contributed equally to this work
Changli Wang, email: email@example.com
Guoguang Ying, email: firstname.lastname@example.org
Keywords: adenocarcinoma, tight junction, claudin-3, EGF, proliferation
Received: April 22, 2016 Accepted: January 04, 2017 Published: February 01, 2017
Claudins are essential for the formation and maintenance of tight junctions (TJ). The altered expression of claudin proteins has been described in a variety of malignancies. However, the alteration of these proteins in lung adenocarcinoma (ADC) are poorly understood. Therefore, we report, based on the protein expression analysis of a total of 275 patient samples, that claudin-3 (CLDN3) expression is significantly increased in ADC tissues and is associated with cancer progression, correlating significantly with the poor survival of ADC patients (p=0.041&0.029). More importantly, forcing CLDN3 expression in ADC cells without endogenous CLDN3 expression resulted in significant increases in the cell proliferation, anchorage-dependent growth, migration and drug-resistance. In addition, epidermal growth factor (EGF) signaling pathway modulates the expression of claudins in a number of solid tumors. However, the mechanism of tight junction regulation by EGF in ADC remains unclear. To investigate this mechanisms, ADC cell lines were treated with EGF and its inhibitor. EGF unregulated CLDN3 expression via the MEK/ERK or PI3K/Akt signaling pathways and was required for the maintenance of baseline CLDN3 expression. Furthermore, downregulation of CLDN3 expression in ADC cell was found to prevent the EGF-induced increase in cell proliferation. In conclusion, our results demonstrate a novel role of CLDN3 overexpression in promoting the malignant potential of lung adenocarcinoma. This function is potentially regulated by the EGF-activated MEK/ERK and PI3K-Akt pathways.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.